Skip to main content
MSR India Limited logo

MSR India Limited — Investor Relations & Filings

Ticker · 508922 ISIN · INE331L01026 LEI · 9845003D4C9A2EO6E749 BSE.NS Manufacturing
Open in API
Filings indexed 235 across all filing types
Latest filing 2023-08-02 Regulatory Filings
Country IN India
Listing BSE.NS 508922

About MSR India Limited

http://msrindia.in/

MSR India Limited specializes in the manufacturing and distribution of diverse product lines, primarily focusing on copper-based consumer goods and industrial components. The company is widely recognized for its Dr. Copper brand, which features seamless copper water bottles designed to leverage the antimicrobial properties of copper for health benefits. Beyond consumer products, the firm operates in the precision engineering sector, producing extruded copper products and specialized components for various industrial applications. Its manufacturing capabilities include advanced extrusion and fabrication processes. The company emphasizes innovation in product design and material science to cater to both domestic and international markets. Its portfolio also extends into the fast-moving consumer goods sector, where it develops and markets a range of household and personal care items.

Recent filings

Filing Released Lang Actions
MSR INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 ,inter alia, to consider and approve Un-audited Financial Results of the Company
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to a stock exchange (BSE Limited) informing about an upcoming Board Meeting scheduled to consider the Un-Audited Financial Results for the quarter ended June 30, 2023. It references regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) regulations, which pertains to disclosures about board meetings. The document does not contain the financial results themselves but is an announcement of the meeting where such results will be considered and likely announced. The document length is short (1472 characters), and it serves as a notification rather than a report or detailed financial statement. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-08-02 English
Sale of Land and Properties of the Company.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to BSE Limited referencing a request to waive interest charges related to a period from April 2022 to December 2022. It mentions the sale of land and properties approved by shareholders at an Extra-Ordinary General Meeting held on 5th May 2021. The letter is signed by the Whole-time Director & CFO. The document references Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement or intimation to the stock exchange about a corporate action (sale of land and properties) and a request related to financial charges, but it does not contain financial statements, detailed financial analysis, or a report. The document length is short (2177 characters), and it is primarily an announcement/intimation letter rather than a full report or detailed financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and disclosures that do not fit other specific categories.
2023-07-26 English
Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to BSE Limited regarding the closure of the trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the dates for the trading window closure related to the upcoming declaration of unaudited financial results for the quarter ended 30.06.2023. The content is an announcement about trading restrictions and compliance with insider trading regulations, not a financial report or earnings release itself. The document length is short (1259 characters), and it serves as a regulatory announcement to the stock exchange. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-29 English
Clarification
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) providing a clarification regarding significant price movement of the company's stock. It states that there are no specific events impacting the price and assures compliance with SEBI listing regulations. The document is short (1538 characters) and does not contain any financial data, report, or detailed analysis. It is a regulatory communication responding to an exchange query rather than a financial report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2023-06-27 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-30 English
Financial Results for the Year ended 31.03.2023
Regulatory Filings
2023-05-29 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.